RECENT ACQUISITION

Ayla Bioscience is headquartered in the United States, with primary operational presence in Colombia, South America, and Jamaica. The company specializes in developing high-demand food and medicinal products derived from fungi and plants, leveraging advanced solid-state fermentation technology.

ZeoTech, Ayla’s new Colombian subsidiary, is serving as the primary scientific, production, and operational hub for all eight of our divisions. Our Jamaica facility will function as a fully operational satellite, focusing on psilocybin research and gourmet mushroom production.

Strategic Synergy Between Facilities
Psilocybin R&D is gaining global acceptance for its potential in treating mental health conditions, though it remains fully unrestricted in only seven countries—Jamaica among them. Through strategic political connections, ZeoTech became, in December 2024, the first Colombian entity legally authorized to conduct full psilocybin research.

Market Potential in the Caribbean
The Caribbean region, home to approximately 44 million residents, welcomed over 32 million tourists last year. Most arrive via cruise ships—each featuring multiple gourmet restaurants—or stay at one of the 450+ all-inclusive resorts, each typically offering four or more gourmet dining venues. This strong demand drives wholesale gourmet mushroom prices in the Caribbean to double or more those in the United States, creating a lucrative opportunity for Ayla’s Jamaica operations.